期刊文献+

麝香保心丸对心力衰竭大鼠内皮素1和肾上腺髓质素水平的影响 被引量:6

Effects of Shexiangbaoxin pills therapy on plasma levels of endothelin-1 and adrenomedullin in rats with heart failure
暂未订购
导出
摘要 目的探讨麝香保心丸对心肌梗死后慢性心力衰竭大鼠血浆内皮素1(ET-1)和肾上腺髓质素(ADM)水平的影响。方法 80只Wistar大鼠随机分为正常对照组(A组,10只)、假手术组(B组,10只)、其余60只制作心力衰竭模型,将制模成功35只大鼠又分对照组(C组,9只)、麝香保心丸小剂量组(D组,9只)、麝香保心丸大剂量组(E组,9只)和阳性药物对照组(F组,8只),采用灌胃法给药。超声心动图检测用药前后大鼠心脏功能,放射免疫法检测ET-1、ADM水平。结果 A组与B组用药前LVEF、左心室舒张末内径(LVEDD)、左心室收缩末内径(LVESD)无显著差异。与B组用药前比较,C组、D组、E组、F组大鼠LVEF明显降低,LVEDD、LVESD明显增加(P<0.01);与C组用药后比较,E组大鼠LVEF明显升高,LVEDD、LVESD明显减小(P<0.05),D组、F组LVESD明显减小(P<0.05);与B组比较,C组大鼠ET-1、ADM水平明显升高(P<0.05,P<0.01);与C组比较,D组、E组、F组大鼠ET-1水平明显降低(P<0.05,P<0.01),E组ADM水平明显降低(P<0.01)。结论麝香保心丸可能通过改善心肌血供,进而抑制慢性心力衰竭时神经内分泌系统的激活,并起到了有效治疗作用。 Objectives To investigate the effects of Shexiangbaoxin pills(SXBXP) on the plasma levels of endothelin-1 (ET-1) and adrenomedullin (ADM) in rats with chronic heart failure (CHF). Methods Models of CHF were established by anterior descending coronary artery liga- tion. Fifty-four Wistar rats were randomly divided into six groups: control group(group A, n 10) ,sham operation group(group B, n = 10),CHF model group(group C, n = 8), small-dose SXBXP group(group D, n = 9) ,large-dose SXBXP group(group E, n = 9) and positive medicine group(group F, n ^- 8). Heart function was examined by echocardiography before and after thera- py,plasma ET-1 and ADM levels were measured by radioimmunoassay. Results Compared with group I3 before therapy,the ejection faction of left ventricle(LVEF) of groups C,D,E,F was sig- nificantly decreased (P 〈 0. 01) , after therapy,plasma levels of ET-1 and ADM of group C were markedly increased (P 〈0.05, P 〈 0.01). Compared with group C, LVEF of group E was signifi- cantly improved (P 〈 0.05) ,plasma levels of ET-1 and ADM of group E were markedly decreased (P〈 0.01) ,plasma levels of ET-1 in groups D and F were significantly decreased (P 〈 0.05), LVEF and plasma levels of ADM of groups D and F decreased. Conclusions Heart function was ameliorated by SXBXP therapy in rats with CHF. The therapeutical effect of SXBXP may be re- lated to better blood supply for myocardium and inhibition of neuroendocrine activation.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2010年第5期448-451,共4页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
基金 中国中西医结合学会科研基金(2008-01)
关键词 心肌梗死 心力衰竭 内皮缩血管肽1 肾上腺髓质素 神经分泌系统 myocardial infarction heart failure endothelin-1 adrenomedulin neurosecretory sys- tems
  • 相关文献

参考文献4

二级参考文献22

共引文献166

同被引文献90

  • 1李勇.麝香保心丸促进治疗性血管新生的实验研究[J].中国社区医师,2006,22(9):19-20. 被引量:8
  • 2杜立建,李静君,吴俊喜.心室重构的中医药治疗进展[J].现代中西医结合杂志,2007,16(15):2169-2171. 被引量:6
  • 3吴振军.心力衰竭大鼠心肌细胞凋亡与肺血管结构改变及药物干预的研究.北京:中国协和医科大学出版社,2004.48-50.
  • 4Huang W,Xie C,Zhou H,et al.Association of the angiotensin-converting enzyme gene polymorphism with chronic heart failure in Chinese Han patients.Eur J Heart Fail,2004,6:23-27.
  • 5Hasegawa H,Komuro I.The progress of the study of RAAS.Nippon Rinsho,2009,67:655-661.
  • 6Wang S,Zheng Z,Weng Y,et al.Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts.Life Sei,2004,74:2476-2478.
  • 7Schluter KD,Wenzel S.Angiotensin Ⅱ:A hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks.Pharmacol Ther,2008,119:311 -325.
  • 8Asano K,Dutcher DL,Port JD,et al.Selective downregulation of the angiotensin Ⅱ AT1-receptor subtype in failing human ventricular myocardium.Circulation,1997,95:1193-1200.
  • 9Bartunek J,Weinberg EO,Tajim M,et al.Angiotensin Ⅱ type 2receptor blockade amplifies the early signals of cardiac growth response to angiotensin Ⅱ in hypertrophied hearts.Circulation,1999,99:22-25.
  • 10Matsubaca H.Pathophysiological role of angiotensin Ⅱ type 2 receptor in cardiovascular and renal diseases.Circ Res,1998,83:1182-1191.

引证文献6

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部